Results 211 to 220 of about 139,183 (310)

Treatment Selection and Prioritization for the EJS ACT‐PD MAMS Trial Platform

Movement Disorders, EarlyView.
Abstract Background There are currently no disease‐modifying therapies (DMTs) registered for Parkinson's disease (PD). The Edmond J. Safra Accelerating Clinical Trials in Parkinson Disease (EJS ACT‐PD) initiative will expedite clinical assessment of putative DMTs through a multi‐arm multistage (MAMS) trial, testing several treatments against a common ...
Cristina Gonzalez‐Robles, Dilan Athauda, Thomas R. Barber, Roger A. Barker, David T. Dexter, Susan Duty, Romy Ellis‐Doyle, Sonia Gandhi, Joel Handley, Edwin Jabbari, Keith Martin, Kevin McFarthing, Georgia Mills, Heather Mortiboys, Stephen Mullin, Rebecca Petty, Esther Sammler, Paula Scurfield, Simon R.W. Stott, George K. Tofaris, Li Wei, Caroline H. Williams‐Gray, Alan Wong, Marie‐Louise Zeissler, Richard K. Wyse, Camille B. Carroll, Thomas Foltynie, Oliver Bandmann, Anthony H.V. Schapira, on behalf of the EJS ACT‐PD Consortium   +29 more
wiley   +1 more source

Undifferentiated connective tissue disease: the diagnoses critically revised-experience of a single center. [PDF]

Clin Exp Med
Cavazzana I, Semeraro P, Tomasi C, Kessler ES, Piantoni S, Caproli A, Fredi M, Franceschini F.   +7 more
europepmc   +1 more source

Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody. [PDF]

, 1984
Michael B. Mathews, Morris Reichlin, Graham R.V. Hughes, Robert M. Bernstein   +3 more
openalex   +1 more source

Erythematoviolaceous Papules and Plaques on Sun‐Exposed Areas

JEADV Clinical Practice, EarlyView.
Ana C. Martín‐Zamora, Alejandra Gamboa‐Flores, Jaime Pozuelo‐Díaz, Marcela Campos‐Hidalgo   +3 more
wiley   +1 more source

Regulation of the terminal complement cascade in adipose tissue for control of its volume, cellularity, and fibrosis

Obesity, EarlyView.
Abstract White adipose tissue (WAT) is a reservoir for various pathogens and their products, such as lipopolysaccharides. Therefore, it must be equipped with a defense mechanism connected with the activation of innate immunity. This explains the phenomenon that adipocytes express components of the classical and alternative complement pathways, which ...
Ilja L. Kruglikov, Philipp E. Scherer
wiley   +1 more source

Autoantibodies targeting angiotensin-converting enzyme 2 are prevalent and not induced by SARS-CoV-2 infection. [PDF]

FASEB J
Galipeau Y, Castonguay N, McCluskie PS, Sonoda MT, Keeshan A, Collins E, Arnold C, Pelchat M, Burns K, Cooper C, Langlois MA.   +10 more
europepmc   +1 more source

Human autoantibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus patients. [PDF]

, 1987
Russell W. Eyre, John R. Stanley
openalex   +1 more source

Scarring Alopecia in a 66‐Year‐Old Woman

JEADV Clinical Practice, EarlyView.
Sergio Castillo Pinto, Lina M. Isaza, Isabel Cristina Cuellar   +2 more
wiley   +1 more source

Identification of novel autoantibodies in Sjögren's disease. [PDF]

Front Immunol
Engelke F, Budde P, De Vita S, Dörner T, Ernst D, Gras J, Heidecke H, Kilian AL, Kniesch K, Lindemann AS, Quartuccio L, Ritter J, Schulze-Forster K, Seeliger B, Zucht HD, Witte T.   +15 more
europepmc   +1 more source

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source